InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
15
T+90 hit rate
0%
T+90 mean return
-24.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by McNeill Jonathan, Executive. Director active across 2 companies, notably Dyne Therapeutics, Inc.. Aggregated, 26 disclosures have been recorded. Split: 0 buy · 15 sells. Total volume traded: €814k. History available since 20 September 2021. The latest transaction was filed on 19 August 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations26 total
20,549 sharesOrdinary SharesSEC:0001628280-26-044885:0
2,400 shares@ US$45.017.5% of flowCommon StockSEC:0000950170-24-099127:0
1,823 shares@ US$31.344.1% of flowCommon StockSEC:0000950170-24-072151:0
2,279 shares@ US$28.204.5% of flowCommon StockSEC:0000950170-24-062075:0
86,159 shares@ US$5.5433.5% of flowCommon StockSEC:0000950170-24-030484:0
2,434 shares@ US$25.854.4% of flowCommon StockSEC:0000950170-24-029607:0
4,268 shares@ US$0.730.2% of flowCommon StockSEC:0000950170-24-024299:0
20,000 shares@ US$0.731.0% of flowCommon StockSEC:0000950170-24-008062:0
11,900 shares@ US$13.1010.9% of flowCommon StockSEC:0000950170-24-002278:0
1,245 shares@ US$10.721.0% of flowCommon StockSEC:0001209191-23-058330:0
96,158 shares0Common StockSEC:0001209191-23-055530:0
1,261 shares@ US$9.412.6% of flowCommon StockSEC:0001209191-23-050173:0
1,266 shares@ US$10.410.9% of flowCommon StockSEC:0001209191-23-049360:0
1,000 shares@ US$13.000.9% of flowCommon StockSEC:0001209191-23-037167:0
1,000 shares@ US$13.000.9% of flowCommon StockSEC:0001209191-23-018981:0
10,000 shares@ US$0.730.5% of flowCommon StockSEC:0001209191-23-004345:0
30,150 shares@ US$11.5725.2% of flowCommon StockSEC:0001209191-23-003013:0
40,000 shares0Common StockSEC:0001209191-22-060972:0
1,246 shares@ US$13.701.3% of flowCommon StockSEC:0001209191-22-050891:0
494 shares@ US$14.050.5% of flowCommon StockSEC:0001209191-22-050122:0
504 shares@ US$4.950.0001% mcap11.5% of flowCommon StockSEC:0001209191-22-037150:0
481 shares@ US$8.730.0001% mcap18.4% of flowCommon StockSEC:0001209191-22-018536:0
25,311 shares0Common StockSEC:0001209191-21-069425:0
25,311 shares0Common StockSEC:0001209191-21-069425
545 shares@ US$15.610.6% of flowCommon StockSEC:0001209191-21-057325
25 of 26 declarations
About McNeill Jonathan
Jonathan McNeill is an Executive at Dyne Therapeutics, Inc. He is involved in managing the company's operations and strategy, aiming to strengthen its position in the biopharmaceutical market.
